Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

BeiGene - 9 Year Stock Split History | ONC

Stock split history for BeiGene since 2016. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
  
BeiGene Annual Stock Splits
BeiGene Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $17.962B $2.459B
BeiGene, Ltd. is a biotechnology company which focused on immuno-oncological therapeutics. The company's clinical-stage drug candidates include BGB-3111, BGB-283, BGB-290, and BGB-A317. BeiGene, Ltd. is based in Camana Bay, Cayman Islands.
Stock Name Country Market Cap PE Ratio
Heidelberg Materials AG (HDLMY) Germany $22.212B 0.00
BrightSphere Investment Group (AAMI) United States $0.962B 11.46
Viad Corp (PRSU) United States $0.883B 39.27
Westaim (WEDXD) Canada $0.461B 12.39
Coliseum Acquisition (RAIN) United States $0.040B 0.00
ILearningEngines (AILEQ) United States $0.000B 0.00